SinglePoint (OTC: $SING) Signs Reseller Agreement for High Risk Merchant Processing

SEATTLE, WA - May 9, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING) has signed a new agreement enabling the company to start onboarding 'high risk' merchant accounts. SinglePoint has committed much time and resources to finding solutions for businesses that are considered 'high risk'. Under this new agreement the company can now start onboarding these businesses. Once a business is approved they will be able to sell their products and services just as any other business does. This is another big step in solidifying SinglePoint's position in the payments space. The next milestone will be working to integrate this solution into the company's Pay by Text solution.
 
Being able to process high risk accounts is a lucrative industry and company executives believe this is not only a viable solution but a profitable one as well. There are over 100 business types that are considered high risk including, auctions, vape pen sales, gambling, online gaming and more. The cannabis industry is projected to reach $24.5 billion by 2025. The company believes when the banks do open and start accepting cannabis businesses they will start out as a high-risk merchant.
Read more: Cannabis Stock News

GIVEMESPORT to market this ground-breaking eSports event to its massive worldwide audience on the web
 
May 8th, 2017 – Toronto, Canada and London, U.K. - Breaking Data Corp. (TSX VENTURE:BKD, OTC: BKDCD) (“Breaking Data” or the "Company")is pleased to announce that it has partnered with McLaren to market World’s Fastest Gamer – the world’s most intense and demanding competition for virtual racers. It’s a contest that will see the winner offered the best job in eSports – a role with the Formula 1 team as one of its official simulator drivers.
 
World’s Fastest Gamer is a collaboration between GIVEMESPORT, global sports and technology brand McLaren, founding partner Logitech G, a global leader in gaming gear and the founder of virtual motorsport’s famous GT Academy, Darren Cox, sports and eSport racing innovator Sparco.
Read more: Breaking Data’s (TSXV: $BKD.V; OTC: $BKDCD) GIVEMESPORT Partners with McLaren Racing for the...
TORONTO, ONTARIO and LONDON, UNITED KINGDOM - May 4, 2017 (Investorideas.com Newswire) Breaking Data Corp. (TSX VENTURE:BKD) (OTC PINK:BKDCD) ("Breaking Data" or the "Company") is pleased to announce that its recent acquisition GIVEMESPORT has seen its Facebook video plays go from 239 million in its first quarter working with Facebook video, (2016 - Apr/May/Jun) rising to over 734 million Facebook video plays last quarter, (2017 - Jan/Feb/Mar) with no material increase in associated costs.
 
Over the last 12 months there has been a strong 207% quarterly increase, with quarter-on-quarter growth that is a continuing trend.
Read more: #AI News: Artificial Intelligence Company Breaking Data (TSXV: $BKD.V) (OTC: $BKDCD) Sees...

Updates Shareholders on Initiatives to Strengthen Corporate Value 

SEATTLE (May 03, 2017) (Investorideas.com Newswire) SinglePoint, Inc. (OTC: SING), a holding company specialized in the acquisition of small to mid-sized companies with an emphasis on new technologies, todayissues an update on current and future initiatives to maximize corporate value and increase shareholder communication.

SinglePoint recently enhanced its corporate website, www.SinglePoint.com, to provide investors a clear view of the company’s endeavors and market value. SinglePoint.com is designed to increase shareholder value by driving more engagement for potentinal acquisitions and sales for the acquired companies. Investors can sign up for updates by visiting http://ir.singlepoint.com/email-alerts,and can access the latest research report on SinglePoint at LAdavisandassociates.com

Read more: SinglePoint Inc ( SING )

Provides Update on its Congenital #CMV Phase I Clinical Study

Positive Safety Review and Final Vaccination of All Participants
 
CAMBRIDGE, MA (May 2, 2017) – (Investorideas.com Newswire) VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (“VBI”) today provided an update on its cytomegalovirus (“CMV”) Phase I clinical study, which is assessing the safety and tolerability of VBI’s vaccine candidate to prevent congenital CMV infection. Congenital CMV infection is a leading cause of birth defects, affecting more live births than Down syndrome or fetal alcohol syndrome, making it a key public health priority.
 
Upon review of all safety data up to one month after second immunizations in VBI’s prophylactic CMV Phase I clinical study, the Data and Safety Monitoring Board (“DSMB”) unanimously recommended the continuation of the study without modification. No safety signals have been detected, suggesting VBI’s CMV vaccine candidate is safe and well-tolerated.
Read more: VBI Vaccines@VBIVaccines (Nasdaq: $VBIV) (TSX: $VBV)